ATE541560T1 - Zusammensetzung mit mehrfach ungesättigten fettsäuren und aktivierter holzkohle - Google Patents

Zusammensetzung mit mehrfach ungesättigten fettsäuren und aktivierter holzkohle

Info

Publication number
ATE541560T1
ATE541560T1 AT08845987T AT08845987T ATE541560T1 AT E541560 T1 ATE541560 T1 AT E541560T1 AT 08845987 T AT08845987 T AT 08845987T AT 08845987 T AT08845987 T AT 08845987T AT E541560 T1 ATE541560 T1 AT E541560T1
Authority
AT
Austria
Prior art keywords
composition
fatty acids
polyunsaturated fatty
activated charcoal
charcoal
Prior art date
Application number
AT08845987T
Other languages
English (en)
Inventor
Catherine Kabaradjian
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Application granted granted Critical
Publication of ATE541560T1 publication Critical patent/ATE541560T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08845987T 2007-10-30 2008-10-21 Zusammensetzung mit mehrfach ungesättigten fettsäuren und aktivierter holzkohle ATE541560T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291306 2007-10-30
PCT/EP2008/008882 WO2009056247A1 (en) 2007-10-30 2008-10-21 Composition comprising polyunsaturated fatty acids and activated charcoal

Publications (1)

Publication Number Publication Date
ATE541560T1 true ATE541560T1 (de) 2012-02-15

Family

ID=40344798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08845987T ATE541560T1 (de) 2007-10-30 2008-10-21 Zusammensetzung mit mehrfach ungesättigten fettsäuren und aktivierter holzkohle

Country Status (15)

Country Link
US (1) US20100260893A1 (de)
EP (1) EP2214638B1 (de)
AR (1) AR070759A1 (de)
AT (1) ATE541560T1 (de)
AU (1) AU2008317920B2 (de)
BR (1) BRPI0818568A2 (de)
CA (1) CA2703816C (de)
ES (1) ES2379034T3 (de)
MX (1) MX2010003703A (de)
PE (1) PE20091076A1 (de)
PL (1) PL2214638T3 (de)
RU (1) RU2485940C2 (de)
TW (1) TW200942229A (de)
UY (1) UY31410A1 (de)
WO (1) WO2009056247A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US20130108745A1 (en) * 2010-07-01 2013-05-02 Delante Health As Coated effervescent tablet
US20130115306A1 (en) * 2011-11-09 2013-05-09 Denovo Inc. Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract
RU2524358C2 (ru) * 2012-07-24 2014-07-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
CN105339006A (zh) * 2013-05-10 2016-02-17 尼特罗米加公司 含有脂肪酸和亚硝酸盐的营养或膳食补充剂
EA025006B1 (ru) * 2013-08-22 2016-11-30 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
CN105935145B (zh) * 2015-12-18 2019-09-20 重庆两江药物研发中心有限公司 一种鱼油植物甾醇复合片剂及其制备方法
CN105919946B (zh) * 2016-05-31 2019-03-12 福格森（武汉）生物科技股份有限公司 一种dha微丸的制备方法
EP3554265A1 (de) * 2016-12-15 2019-10-23 DSM IP Assets B.V. Mischformulierung mit silikat und mikrobiellen und / oder pflanzenzellen mit einer mehrfach ungesättigten fettsäure mit mindestens 20 kohlenstoffatomen (lc-pufa)
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702031A1 (de) 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0892587A (ja) 1994-09-22 1996-04-09 Baiotsukusu:Kk 魚臭のマスキング法
JP3534881B2 (ja) 1995-02-23 2004-06-07 太陽化学株式会社 乳化組成物
US6630192B2 (en) 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
EP1039892B1 (de) * 1997-02-21 2004-04-28 Abbott Laboratories Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
EP1155620B1 (de) * 2000-05-18 2005-08-10 Q-mega healthcare A/S Nahrungsergänzungsmittel mit Vitaminen, Mineralien und mehrfach ungesättigten Fettsäuren
JP2002204656A (ja) 2001-01-10 2002-07-23 Yakult Honsha Co Ltd 発酵乳飲食品及びその製造方法
DE20105126U1 (de) 2001-03-23 2002-01-31 Bartz, Volker, 35440 Linden Fischöl zur oralen Einnahme
MXPA03011966A (es) * 2001-06-25 2004-03-26 Pharmacia Corp Metodo y dispositivo para producir tabletas revestidas por compresion.
DE60301677T2 (de) * 2002-02-04 2006-07-06 Kyowa Hakko Kogyo Co., Ltd. Pharmazeutische und Lebenmittelzusammensetzungen mit einem Di- oder Oligosaccharid, das die Insulinfreisetzung steigert
AU2003259904A1 (en) 2002-08-14 2004-03-03 E.I. Du Pont De Nemours And Company Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles
EP1551570A4 (de) * 2002-08-14 2008-04-09 Du Pont FESTES RIESELFûHIGES PULVER MIT HOHER FLÜSSIGKEITSLADUNG
BRPI0414818A (pt) 2003-09-26 2006-11-14 Nestec Sa composição nutricional com ácidos graxos insaturados e elementos traço
SI1566173T1 (sl) * 2004-02-20 2006-12-31 Mattern Udo Farmacevtska zmes za oralno aplikacijo in postopek njene priprave
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
ES2332695B1 (es) * 2005-08-03 2011-01-31 Sasol Technology (Proprietary) Limited Transporte y montaje de recipientes muy grandes.
GB0516069D0 (en) * 2005-08-04 2005-09-14 Imp College Innovations Ltd Pharmaceutical and use thereof

Also Published As

Publication number Publication date
EP2214638A1 (de) 2010-08-11
TW200942229A (en) 2009-10-16
AU2008317920B2 (en) 2014-03-13
RU2010121714A (ru) 2011-12-10
RU2485940C2 (ru) 2013-06-27
MX2010003703A (es) 2010-07-30
AU2008317920A1 (en) 2009-05-07
US20100260893A1 (en) 2010-10-14
AR070759A1 (es) 2010-05-05
BRPI0818568A2 (pt) 2015-04-22
WO2009056247A1 (en) 2009-05-07
UY31410A1 (es) 2009-05-29
EP2214638B1 (de) 2012-01-18
PE20091076A1 (es) 2009-07-25
ES2379034T3 (es) 2012-04-20
CA2703816A1 (en) 2009-05-07
PL2214638T3 (pl) 2012-06-29
CA2703816C (en) 2016-07-19

Similar Documents

Publication Publication Date Title
ATE541560T1 (de) Zusammensetzung mit mehrfach ungesättigten fettsäuren und aktivierter holzkohle
LT2315740T (lt) Acetilinti riebalų rūgščių salicilatai ir jų panaudojimas
IL205362A0 (en) Medium - chain length fatty acids and glycerides as nephroprotection agents
EP2448431A4 (de) Mit omega-3-fettsäure angereicherte backwaren und riegelzusammensetzungen
BRPI0921467A2 (pt) Enzimas e métodos para produzir ácidos graxos ômega-3
BRPI0911606A2 (pt) Polipeptídeo e métodos para produzir triacilgliceróis compreendendo ácidos graxos modificados
ZA201005962B (en) Lipases with high specificity towards short chain fatty acids and uses thereof
DK2132317T3 (da) Delta-8-desaturaser og anvendelse heraf i fremstillingen af polyumættede fedtsyrer
EP2197289A4 (de) Feste fettzusammensetzungen, die mehrfach ungesättigte fettsäuren enthalten, und ihre verwendungen und herstellung
PL2408426T3 (pl) Kompozycje dooczne na bazie wielonienasyconych kwasów tłuszczowych omega-3 i omega-6
EP2324119A4 (de) Mutante delta5-desaturasen und ihre verwendung bei der herstellung von mehrfach ungesättigten fettsäuren
BRPI0914928A2 (pt) Composição nutricional com aminoácidos livres e lipídios estruturados
DE602007003093D1 (de) Nahrungsmittel mit Bakterien und Sorbitan-Fettsäure
EP2205677A4 (de) Vernetzbare fluorpolymerzusammensetzung und verwendungen davon
GB2464886B (en) Preparation of fatty acids in solid form
PL2910123T3 (pl) Poddana obróbce gliceryna z biodiesla
PT2842555T (pt) Derivados-alfa de ácidos gordos cis-monoinsaturados para uso como medicamentos no tratamento de diabetes
BRPI1012696A2 (pt) composicao nutricional compreendendo curminaoides e metodos de fabricacao
EP2099295A4 (de) Prophylaxe und behandlung des vorhofflimmerns mit omega-3-fettsäuren
PL2214628T3 (pl) Kompozycja ulegająca rozpadowi w jamie ustnej, zawierająca wielonienasycone kwasy tłuszczowe bez przykrej woni lub smaku
GB2444896B (en) Compositions comprising polyunsaturated fatty acids
EP2512268A4 (de) Mit omega-3-fettsäure angereicherte fleischzusammensetzungen
ZA200904583B (en) Dual composition with warming and analgesic effects
GB0713264D0 (en) Improvements in and relating to luminaries
ZA200810831B (en) Formulations with feruloyl glycerides and methods of preparation